Showing results (41-50 of 75) with videos related to

Sort By:
Pageof 8
International Journal of Radiation Oncology, Biology, Physics|July 2, 2005
Thymidine analogues to assess microperfusion in human tumorsHilde L Janssen, Anna S Ljungkvist, Paul F Rijken, et al.
International Journal of Radiation Oncology, Biology, Physics|April 19, 2006
Hypoxia in human colorectal adenocarcinoma: comparison between extrinsic and potential intrinsic hypoxia markersLaurence Goethals, Annelies Debucquoy, Christiaan Perneel, et al.
Biorxiv : the Preprint Server for Biology|April 22, 2024
TRIP12 governs DNA Polymerase β involvement in DNA damage response and repairBurcu Inanc, Qingming Fang, Joel F Andrews, et al.
Cancer Research|September 14, 2019
Drug Sensitivity Prediction Models Reveal a Link between DNA Repair Defects and Poor Prognosis in HNSCCPaul B M Essers, Martijn van der Heijden, Caroline V M Verhagen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 24, 2004
Differentiation-associated staining with anti-pimonidazole antibodies in head and neck tumorsHilde L K Janssen, Frank J Hoebers, Debbie Sprong, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 16, 2020
Epithelial-to-mesenchymal transition is a prognostic marker for patient outcome in advanced stage HNSCC patients treated with chemoradiotherapyMartijn van der Heijden, Paul B M Essers, Caroline V M Verhagen, et al.
International Journal of Radiation Oncology, Biology, Physics|May 26, 2005
Hypoxic cell turnover in different solid tumor linesAnna S E Ljungkvist, Johan Bussink, Johannes H A M Kaanders, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 30, 2010
HPV and high-risk gene expression profiles predict response to chemoradiotherapy in head and neck cancer, independent of clinical factorsMonique C de Jong, Jimmy Pramana, Joost L Knegjens, et al.
Pageof 8